AMICUS THERAPEUTICS

Amicus Therapeutics (Nasdaq:FOLD) is a biopharmaceutical company at the forefront of developing therapies for rare and orphan diseases. The Company has a robust pipeline of novel, first-in-class, small molecules called pharmacological chaperones for the treatment of lysosomal storage diseases (LSDs). These chaperones may offer a dual-treatment approach for Fabry, Pompe, Gaucher and other LSDs. As orally administered monotherapy agents, pharmacological chaperones are designed to bind to, stabilize and increase the activity of a patient’s own misfolded enzyme. In combination with enzyme replacement therapy (ERT), pharmacological chaperones may improve the uptake of the infused enzyme and potentially improve ERT outcomes.

#SimilarOrganizations #People #Financial #Website #More

AMICUS THERAPEUTICS

Social Links:

Facebook

Twitter

Industry:

Biotechnology Health Care Pharmaceutical Therapeutics

Founded:

2002-01-01

Address:

Cranbury, New Jersey, United States

Country:

United States

Website Url:

http://www.amicusrx.com

Total Employee:

501+

Status:

Active

Contact:

(609)662-200

Email Addresses:

[email protected]

Total Funding:

843.05 M USD

Technology used in webpage:

LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome Domain Not Resolving Euro Amazon IPv6 JsDelivr

Similar Organizations

agile-therapeutics-logo

Agile Therapeutics

Agile Therapeutics is pharmaceutical company developing contraceptive healthcare products for women.

aimmune-therapeutics-logo

Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

aztherapies-logo

AZTherapies

AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.

koya-medical-logo

Koya Medical

Koya Medical is a transformative healthcare company developing breakthrough treatments for lymphedema and venous diseases.

munogenics-logo

Munogenics

Munogenics is dedicated to developing therapies for the treatment of a wide variety of cancers in both humans and animals.

iveric-bio-logo

IVERIC bio

IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.

pinpoint-therapeutics-logo

Pinpoint Therapeutics

Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.

not_available_image

Sorriso Pharmaceuticals

Sorriso Pharmaceuticals is a biotech firm developing disease-modifying antibodies for the treatment of inflammatory diseases.

vigeo-therapeutics-logo

Vigeo Therapeutics

Vigeo Therapeutics is a biopharmaceutical company developing novel therapeutic agents intended to treat advanced malignant tumors.

Current Advisors List

sol-barer_image

Sol Barer Member of the Board of Directors @ Amicus Therapeutics
Board_member

stephen-bloch_image

Stephen Bloch Board Member @ Amicus Therapeutics
Board_member

m-james-barrett_image

M. James Barrett Board Member @ Amicus Therapeutics
Board_member

james-topper_image

James Topper Board Member @ Amicus Therapeutics
Board_member

mike-raab_image

Mike Raab Board Member @ Amicus Therapeutics
Board_member

Current Employees Featured

john-crowley_image

John Crowley
John Crowley Executive Chairman @ Amicus Therapeutics
Executive Chairman
2005-01-01

jayne-gershkowitz_image

Jayne Gershkowitz
Jayne Gershkowitz Chief Patient Advocate @ Amicus Therapeutics
Chief Patient Advocate
2016-05-01

bradley-l-campbell_image

Bradley L. Campbell
Bradley L. Campbell President & Chief Executive Officer @ Amicus Therapeutics
President & Chief Executive Officer
2006-01-01

jayne-gershkowitz_image

Jayne Gershkowitz
Jayne Gershkowitz Senior Vice President & Chief Patient Advocate @ Amicus Therapeutics
Senior Vice President & Chief Patient Advocate
2015-05-01

hung-do_image

Hung Do
Hung Do Chief Science Officer @ Amicus Therapeutics
Chief Science Officer
2015-06-01

david-clark_image

David Clark
David Clark Chief People Officer @ Amicus Therapeutics
Chief People Officer
2018-10-01

jay-barth_image

Jay Barth
Jay Barth Chief Medical Officer @ Amicus Therapeutics
Chief Medical Officer
2014-03-01

alex-fell_image

Alex Fell
Alex Fell Head Ethics, Compliance and DPO International @ Amicus Therapeutics
Head Ethics, Compliance and DPO International
2020-07-01

jayne-gershkowitz_image

Jayne Gershkowitz
Jayne Gershkowitz Vice President, Patient Advocacy & Public Policy @ Amicus Therapeutics
Vice President, Patient Advocacy & Public Policy
2013-01-01

enrique-diloné_image

Enrique Diloné
Enrique Diloné Vice President @ Amicus Therapeutics
Vice President

Founder

john-crowley_image

John Crowley

Stock Details

Company's stock symbol is NASDAQ:FOLD

Acquisitions List

Date	Company	Article	Price
2018-09-20	Celenex	Celenex acquired by Amicus Therapeutics	452 M USD
2015-08-31	Scioderm	Scioderm acquired by Amicus Therapeutics	847 M USD
2013-11-01	Callidus Biopharma	Callidus Biopharma acquired by Amicus Therapeutics	N/A